FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387384001: Opium preparation (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1461562010 Opium preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481480010 Opium preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Opium preparation Is a Opium false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    opiumtinktur 10 mg/ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Papaveretum [cns narcotic] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Papaveretum [anesthesia] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Papaveretum 10mg/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Papaveretum 20mg/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    papaveretum 15,4 mg + hyoscin 400 µg injektionsvæske, opløsning, ampul a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Papaveretum BP 15.4mg/mL injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Papaveretum BP 7.7mg/mL injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Papaveretum injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Mixed opium alkaloids The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    papaveretum + hyoscinhydrobromid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Product containing opium alkaloid (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Product containing papaveretum (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    opiumtinktur med kamfer 2 mg/5 ml flydende The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Belladonna alkaloid 16.2 mg and opium 30 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Belladonna alkaloid 16.2 mg and opium 60 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some
    Product containing opium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Opium preparation Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    GB English

    US English

    SAME AS association reference set (foundation metadata concept)

    Back to Start